277 related articles for article (PubMed ID: 26394037)
1. Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.
Martorana GM; Schaefer JL; Levine MA; Lukowski ZL; Min J; Meyers CA; Schultz GS; Sherwood MB
PLoS One; 2015; 10(9):e0138054. PubMed ID: 26394037
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single versus multiple injections of the protein saratin for prolonging bleb survival in a rabbit model.
Min J; Lukowski ZL; Levine MA; Meyers CA; Beattie AR; Schultz GS; Samuelson DA; Sherwood MB
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7625-30. PubMed ID: 23033390
[TBL] [Abstract][Full Text] [Related]
3. A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).
Sherwood MB
Trans Am Ophthalmol Soc; 2006; 104():478-92. PubMed ID: 17471357
[TBL] [Abstract][Full Text] [Related]
4. Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model.
Min J; Lukowski ZL; Levine MA; Meyers CA; Beattie AR; Schultz GS; Samuelson DA; Sherwood MB
PLoS One; 2012; 7(4):e35627. PubMed ID: 22558182
[TBL] [Abstract][Full Text] [Related]
5. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery.
Wong TT; Mead AL; Khaw PT
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2018-22. PubMed ID: 15914618
[TBL] [Abstract][Full Text] [Related]
6. Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.
Lukowski ZL; Min J; Beattie AR; Meyers CA; Levine MA; Stoller G; Schultz GS; Samuelson DA; Sherwood MB
J Glaucoma; 2013 Feb; 22(2):145-51. PubMed ID: 21946553
[TBL] [Abstract][Full Text] [Related]
7. Novel combination therapy reduces subconjunctival fibrosis after glaucoma filtration surgery in the rabbit model.
Swogger J; Conner IP; Happ-Smith C; Kemmerer MC; Julian DR; Davis R; Wells A; Schuman JS; Yates CC
Clin Exp Ophthalmol; 2021 Jan; 49(1):60-69. PubMed ID: 33426793
[TBL] [Abstract][Full Text] [Related]
8. Effect of Lovastatin on Wound-Healing Modulation After Glaucoma Filtration Surgery in a Rabbit Model.
Park JH; Yoo C; Kim YY
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1871-7. PubMed ID: 27082302
[TBL] [Abstract][Full Text] [Related]
9. α5β1-Integrin inhibitor (CLT-28643) effective in rabbit trabeculectomy model.
Schultheiss M; Schnichels S; Konrad EM; Bartz-Schmidt KU; Zahn G; Caldirola P; Fsadni MG; Caram-Lelham N; Spitzer MS
Acta Ophthalmol; 2017 Feb; 95(1):e1-e9. PubMed ID: 27576860
[TBL] [Abstract][Full Text] [Related]
10. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit.
Cordeiro MF; Constable PH; Alexander RA; Bhattacharya SS; Khaw PT
Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1639-46. PubMed ID: 9224294
[TBL] [Abstract][Full Text] [Related]
11. Bleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex® or mitomycin-C.
SooHoo JR; Seibold LK; Laing AE; Kahook MY
Mol Vis; 2012; 18():714-9. PubMed ID: 22509101
[TBL] [Abstract][Full Text] [Related]
12. CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.
Ma J; Li X; Zhang W; Huang L; Chen M; Xi L; Zhang Z; Duan L; Quan D; Ge J
Curr Eye Res; 2014 Oct; 39(10):982-8. PubMed ID: 24787678
[TBL] [Abstract][Full Text] [Related]
13. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit.
Memarzadeh F; Varma R; Lin LT; Parikh JG; Dustin L; Alcaraz A; Eliott D
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3233-7. PubMed ID: 19182254
[TBL] [Abstract][Full Text] [Related]
14. Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery.
Butler MR; Prospero Ponce CM; Weinstock YE; Orengo-Nania S; Chevez-Barrios P; Frankfort BJ
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4982-90. PubMed ID: 23766475
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery.
Wong TT; Mead AL; Khaw PT
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1097-103. PubMed ID: 12601035
[TBL] [Abstract][Full Text] [Related]
16. The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model.
Ozgonul C; Mumcuoglu T; Gunal A
Curr Eye Res; 2014 May; 39(5):451-9. PubMed ID: 24215335
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks.
Anand N; Arora S; Clowes M
Br J Ophthalmol; 2006 Feb; 90(2):175-80. PubMed ID: 16424529
[TBL] [Abstract][Full Text] [Related]
18. The PLGA implant as an antimitotic delivery system after experimental trabeculectomy.
Rodríguez-Agirretxe I; Vega SC; Rezola R; Vecino E; Mendicute J; Suarez-Cortes T; Acera A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5227-35. PubMed ID: 23800769
[TBL] [Abstract][Full Text] [Related]
19. Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C.
Kessing SV; Flesner P; Jensen PK
J Glaucoma; 2006 Apr; 15(2):84-90. PubMed ID: 16633219
[TBL] [Abstract][Full Text] [Related]
20. Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery.
Van Bergen T; Vandewalle E; Moons L; Stalmans I
Acta Ophthalmol; 2015 Nov; 93(7):667-78. PubMed ID: 25988844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
